Initial Parkinson disease therapy: levodopa, dopamine agonists, or both?
Roach
E S
ES
Department of Neurology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. sroach@wfubmc.edu
D018491:Dopamine Agonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism
D018491:Dopamine Agonists; D007980:Levodopa